Results 121 to 130 of about 43,548 (209)

Non‐acute promyelocytic leukemia variant, acute myeloid leukemia with translocation (11;17)

Clinical Case Reports, 2019
Key Clinical Message t(11;17) is a rare but recognized finding usually found in Acute Promyelocytic Leukemia with variant RARA translocation (APLv). We present a case of Acute Myeloid Leukemia with t(11;17) that has different break points than those ...
Rahaf Altahan, Shatha Altahan, Salem Khalil   +2 more
doaj   +1 more source

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML) [PDF]

, 2010
The t(8;21)(q22;q22) is a frequently occurring aberration in acute myeloid leukemia (AML) (18-20%) and usually correlate with French-America-British (FAB) M2 subtype.
Chang KM,, Ong TC,, Phan CL,, Puteri Jamilatul NMB,, Zubaidah Z,   +4 more
core  

Serendipity: Decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia [PDF]

, 2019
Abboud, Camille N, Abboud, Ramzi, Cashen, Amanda F, DiPersio, John F, Duncavage, Eric J, Han, Se Young, Shirai, Cara Lunn, Welch, John S   +7 more
core   +3 more sources

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials [PDF]

, 2005
Fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) are powerful adverse prognostic indicators for relapse in acute myelold leukemia (AML) but the most efficacious therapy for FLT3/ ITD+ patients is currently unknown.
Burnett, AK, Gale, RE, Hills, R, Kottaridis, PD, Linch, DC, Srirangan, S, Wheatley, K   +6 more
core  

Cytogenetic analysis and FISH of terminal deletion of the long arm of chromosome 9 in a patient with acute promyelocytic leukemia. [PDF]

, 2009
Deletions of the long arm of chromosome 9, del(9)(q22), are rare aberrations specifically found in acute myeloid leukemia (AML). Yamamoto et al, 1999, reported the first case of acute promyelocytic leukemia (APL) with a terminal 9q deletion as a sole ...
Botero, Olga, Quintero Rivera, Fabiola, Sierra, Margarita, Tubo, Taknida, Vásquez Palacio, Gonzalo   +4 more
core  

Therapy-related acute promyelocytic leukemia

Haematologica, 2011
Success in the treatment of cancer has led to an expanding population of survivors with their attendant long-term complications. Treatment with cytotoxic, DNA-interactive drugs and radiation is well known to predispose to the development of secondary tumors, in particular secondary ...
openaire   +3 more sources

All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Absract All-trans-retinoic acid is an integral part in the treatment strategy of acute promyelocytic leukemia (APL) . Here we describe a case of pseudotumor cerebri associated with all-trans retinoic acid (ATRA ) during induction therapy in an adult ...
anoop tm
doaj  

Modern treatment of acute promyelocytic leukemia. [PDF]

Haematologica
Russell N.
europepmc   +1 more source

Primary Indolent Acute Promyelocytic Leukemia. [PDF]

Hematol Rep
Wolfenbarger B, Morera D, Wolfenbarger B, Jillella A, Zheng M.   +4 more
europepmc   +1 more source

Acute promyelocytic leukemia with a novel TTMV::RARA fusion initially presenting as vertebral myeloid sarcoma: a case report. [PDF]

Front Oncol
Ruijia L, Qianqian Z, Xiaohong L, Sen Y, Nan Z, Jing L.   +5 more
europepmc   +1 more source